Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer Immunol Res. 2016 Feb 3;4(3):225–233. doi: 10.1158/2326-6066.CIR-15-0200-T

Figure 3. Increased tissue expression of PSMC5, MYPT1 and TFRC parallels PDA development.

Figure 3

Representative tissue sections from the J9988 study stained for (A) PSMC5, MYPT1 and TFRC are shown. Normal non-neoplastic duct cells (indicated with an N) and cancer cells (indicated with a C). Scale bars = 50 μm. Staining summary for (B) PSMC5 (n = 45), (C) MYPT1 (n = 44) and (D) TFRC (n = 42). PDA glands (black bars) express PSMC5, MYPT1 and TFRC in both cytoplasm and nucleus/membrane. However, minimal staining is evident in non-neoplastic (white bars) pancreatic ducts. *P < 0.01 Fisher exact test.